RayOne Family

RayOne® fully preloaded IOL injection system, designed to deliver without compromise. 

At Rayner, we believe that the only way to create a true, fully preloaded micro incision cataract surgery (MICS) injection system that works consistently without compromise, is to design the system as one - both lens and injector. This was the inspiration behind RayOne®

Preloaded Primary IOL Platform


Vacuole free material for a glistening free IOL

  • Single piece IOL created from Rayacryl® a homogeneous material free of microvacuoles, resulting in a glistening free IOL8
  • Compressible material for delivery through a small incision
  • Excellent handling characteristics with controlled unfolding within the capsular bag
  • Low silicone oil adherence9
  • Excellent uveal biocompatibility13
  • Hydrophilic acrylic material with low inflammatory response10

Reliable optical outcomes and a low rate of post-operative complications

Designed with Rayner's Anti-Vaulting Haptic (AVH) Technology® .Our RayOne® IOL provides proven rotational and centrational stability, and excellent fixation in the capsular bag1

  • Superb centration
    – Maximum offset of only 1 mm 3 months after surgery2
  • Excellent rotational and torsional stability
    – 3.1° mean IOL rotation 3 months after surgery2

360° Optimised Barrier to reduce PCO – Low Nd: YAG capsulotomy rates

Rayner's 360° Amon-Apple Enhanced Square Edge creates an optimum barrier to reduce epithelial cell migration including at the haptic-optic junction7,5

At 12 months 0.6%
At 24 months 1.7%

9.3 ± 5.5 months
(range 2.6 - 22.7 months)

Follow-up period: 5.3 – 29 months

Study of 3,461 patients receiving Rayner 570C IOLs over a 24 month period, Nd:YAG capsulotomy rates were extremely low and comparable with hydrophobic acrylic lenses with square-edge optics.7


Reducing dysphotopsia by design12

  • Rayner’s Enhanced Square Edge Technology shows no general increase in glare from previous models without a square edge7
  • The low refractive index (1.46) of Rayacryl®


  1. Claoué C. Clinical and Surgical Ophthalmology 2008; 26(6): 198-200
  2. Alberdi R et al. J Refract Surg. 2012; 28(10):696-700
  3. Nanavaty MA et al. J Cataract Refract Surg. 2009; 35:663–671
  4. Yagci R et al. Eur J Ophthalmol. 2014 Jul 24; 24(5):688-92
  5. Vyas AV et al. J Cataract Refract Surg 2007; 33:81-87
  6. Johansson B et al. J Cataract Refract Surg. 2007; 33:1565–1572
  7. Mathew RG and Coombes AGA. Ophthalmic Surg Lasers Imaging. 2010 Nov-Dec; 41(6):651-5
  8. Rayner. Data on File. White paper
  9. McLoone E et al. Br J Ophthalmol. 2001; 85:543–545
  10. Richter-Mueksch S et al. J Cataract Refract Surg. 2007; 33:1414–1418
  11. Altmann GE et al. J Cataract Refract Surg. 2005; 31(3): 574-585
  12. Cezón Prieto J and Bautista MJ. J Cataract Refract Surg. 2010; 36:1508-1516
  13. Tomlins PJ et al. J Cataract Refract Surg. 2014; 40:618–625
  14. Pepose JS et al. Graefes Arch Clin Exp Ophthalmol. 2009 Jul;247(7):965-73

*Of those who expressed a preference